Serum Fucosidase Detection Kit Substrate Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current serum fucosidase detection methods face challenges with substrate instability and sensitivity, particularly in the rate method used for clinical applications, which affects the accuracy and reliability of liver cancer and other cancer diagnoses.
Innovation Solution
A serum fucosidase detection kit is developed with a stable and high-sensitivity substrate system, utilizing 2-chloro-p-nitrophenol-α-L-fucoside or polyvinylsulfuric acid potassium salt with reduced coenzyme I or II as stabilizers, along with an enzyme cycling protection system, to enhance substrate stability and interference resistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the rate method is used for AFU detection, then the operation is simple and determination time is short, but the substrate stability is poor and sensitivity needs improvement
Solution Approach 1:
The patent modifies the substrate structure by introducing a chloro group at the 2-position of the p-nitrophenol ring in CNP-AFU. This parameter change in the molecular structure enhances substrate stability while maintaining its reactivity with AFU enzyme, thus resolving the contradiction between fast determination and substrate stability.
Solution Approach 2:
The patent uses a composite substrate system consisting of CNP-AFU (2-chloro-p-nitrophenol-α-L-fucoside) combined with specific buffer components and stabilizers. This composite formulation improves substrate stability without compromising the rapid detection capability, allowing the reaction to complete quickly while maintaining consistent substrate performance.
2Measurement precision
If the fluorescence method is used, then the sensitivity is high, but the instrument requirement is high and automated analysis can't be achieved
Solution Approach 1:
The patent replaces the fluorescence detection system with a colorimetric detection system using CNP-AFU substrate. The chloro-p-nitrophenol group produces a measurable color change upon enzymatic hydrolysis, which can be detected by simple spectrophotometry without requiring complex fluorescence instruments, thus maintaining sensitivity while reducing device complexity.
Solution Approach 2:
The patent utilizes the color-changing property of the chloro-p-nitrophenol group in CNP-AFU. When AFU hydrolyzes the substrate, the released chloro-p-nitrophenol undergoes a visible color change that can be quantified by spectrophotometric measurement, providing high sensitivity detection through a simple optical method that doesn't require sophisticated instrumentation.
3Ease of operation
If the end-point colorimetric method is used, then the operation is simple and equipment requirement is low, but the anti-interference ability is poor and operation time is long
Solution Approach 1:
The patent introduces a chloro substituent at the 2-position of the p-nitrophenol ring, which changes the electronic and steric parameters of the substrate. This modification enhances the substrate's resistance to interference from serum components such as bilirubin and hemoglobin, while maintaining the simplicity of colorimetric detection and reducing required operation time.
Solution Approach 2:
The patent employs a stable, pre-formulated substrate solution (CNP-AFU) that can be used directly without extensive preparation or purification steps. The substrate's inherent stability allows it to resist interference from common serum contaminants, enabling simple operation with short reaction times while maintaining reliability without requiring complex interference removal procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The kit provides a stable substrate that remains effective for at least 12 months, allowing for direct use without re-dissolution, simplifying operations and improving detection sensitivity, leading to accurate and reliable results for cancer diagnosis.
Implementation Method 1
the substrate is enzymatically decomposed to produce a chromophore
Implementation Method 2
the chromophore exhibits a yellow color under alkaline conditions
Implementation Method 3
substrate stability and interference resistance are enhanced through the use of stabilizers such as reduced coenzyme I or II
Data Source
AI summary
Disclosed is a serum fucosidase detection kit. The kit comprises a reagent 1 and a reagent 2, wherein the reagent 1 consists of 50-500 mmol/L of a buffer (pH 4.0-4.5), 1-50 g/L of a surfactant, 1-20 g/L of an anti-interference agent and 0.1-100 g/L of a preservative; and the reagent 2 consists of 50-500 mmol/L of a buffer (pH 7.0-7.5), 2-60 g/L of glucose, 1-20 KU/L of hexokinase, 1-20 KU/L of glucose-6-phosphate dehydrogenase, 0.3-5 g/L of magnesium sulfate, 0.2-5 g/L of a substrate, 1-100 mmol/L of a stabilizer, 0.1-40 g/L of a protective agent and 0.1-100 g/L of a preservative. The kit solves the problems of the poor substrate stability, the poor anti-interference capacity and the low sensitivity which exist universally.